Left Ventricular Contractile Reserve in Asymptomatic Degenerative Mitral Regurgitation: Evaluation and Impact on Outcome.Magne, Julien ; ; et alConference (2012) Detailed reference viewed: 3 (1 ULg) Prognostic Importance of Exercise Brain Natriuretic Peptide in Asymptomatic Degenerative Mitral Regurgitation.Magne, Julien ; ; et alConference (2012) Detailed reference viewed: 1 (1 ULg) Echocardiographic Determinants of Maximal Exercise Capacity in Asymptomatic Patients with Primary Mitral Regurgitation.Magne, Julien ; ; et alConference (2012) Detailed reference viewed: 1 (1 ULg) Outcome prediction in asymptomatic degenerative MR: the usefulness of exercise BNP.Magne, Julien ; ; et alConference (2012) Exercise systolic pulmonary arterial pressure is the main determinant of maximal exercise capacity in asymptomatic patients with primary MRMagne, Julien ; ; et alConference (2012) Detailed reference viewed: 3 (1 ULg) Exercise testing in aortic stenosis and in mitral regurgitationLANCELLOTTI, Patrizio ; Magne, Julien ![]() in Cardiac valvular medicine (2012) Detailed reference viewed: 14 (0 ULg) Stress testing for the evaluation of patients with mitral regurgitationLancellotti, Patrizio ; Magne, Julien ![]() in Current Opinion in Cardiology (2012), 27(5), 492-498 Detailed reference viewed: 12 (0 ULg) ReplyLancellotti, Patrizio ; Magne, Julien ![]() in Journal of the American College of Cardiology (2012), 59(23), 2123 Detailed reference viewed: 9 (0 ULg) Ischemic mitral regurgitation: Not only a bystander; Magne, Julien ; et alin Current Cardiology Reports (2012), 14(2), 180-189 Detailed reference viewed: 10 (0 ULg) Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitationMagne, Julien ; ; Pierard, Luc et alin Heart (2012), 98(7), 587-591 Detailed reference viewed: 10 (0 ULg) Clinical outcome in asymptomatic severe aortic stenosis: Insights from the new proposed aortic stenosis grading classificationLancellotti, Patrizio ; Magne, Julien ; et alin Journal of the American College of Cardiology (2012), 59(3), 235-243 Detailed reference viewed: 12 (1 ULg) Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).; ; et al in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2012), 42(4), 1-44 Detailed reference viewed: 11 (2 ULg) Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients*.LAYIOS, Nathalie ; LAMBERMONT, Bernard ; CANIVET, Jean-Luc et alin Critical Care Medicine (2012), 40(8), 2304-9 OBJECTIVES: : To test the usefulness of procalcitonin serum level for the reduction of antibiotic consumption in intensive care unit patients. DESIGN: : Single-center, prospective, randomized controlled ... [more ▼] OBJECTIVES: : To test the usefulness of procalcitonin serum level for the reduction of antibiotic consumption in intensive care unit patients. DESIGN: : Single-center, prospective, randomized controlled study. SETTING: : Five intensive care units from a tertiary teaching hospital. PATIENTS: : All consecutive adult patients hospitalized for > 48 hrs in the intensive care unit during a 9-month period. INTERVENTIONS: : Procalcitonin serum level was obtained for all consecutive patients suspected of developing infection either on admission or during intensive care unit stay. The use of antibiotics was more or less strongly discouraged or recommended according to the Muller classification. Patients were randomized into two groups: one using the procalcitonin results (procalcitonin group) and one being blinded to the procalcitonin results (control group). The primary end point was the reduction of antibiotic use expressed as a proportion of treatment days and of daily defined dose per 100 intensive care unit days using a procalcitonin-guided approach. Secondary end points included: a posteriori assessment of the accuracy of the infectious diagnosis when using procalcitonin in the intensive care unit and of the diagnostic concordance between the intensive care unit physician and the infectious-disease specialist. MEASUREMENTS AND MAIN RESULTS: : There were 258 patients in the procalcitonin group and 251 patients in the control group. A significantly higher amount of withheld treatment was observed in the procalcitonin group of patients classified by the intensive care unit clinicians as having possible infection. This, however, did not result in a reduction of antibiotic consumption. The treatment days represented 62.6 +/- 34.4% and 57.7 +/- 34.4% of the intensive care unit stays in the procalcitonin and control groups, respectively (p = .11). According to the infectious-disease specialist, 33.8% of the cases in which no infection was confirmed, had a procalcitonin value >1microg/L and 14.9% of the cases with confirmed infection had procalcitonin levels <0.25 microg/L. The ability of procalcitonin to differentiate between certain or probable infection and possible or no infection, upon initiation of antibiotic treatment was low, as confirmed by the receiving operating curve analysis (area under the curve = 0.69). Finally, procalcitonin did not help improve concordance between the diagnostic confidence of the infectious-disease specialist and the ICU physician. CONCLUSIONS: : Procalcitonin measuring for the initiation of antimicrobials did not appear to be helpful in a strategy aiming at decreasing the antibiotic consumption in intensive care unit patients. [less ▲] Detailed reference viewed: 13 (2 ULg) Structural model of the mitral valve included in a cardiovascular closed loop modelPaeme, Sabine ; ; et alPoster (2011, December) A minimal cardiovascular system (CVS) model including mitral valve dynamics has been previously validated in silico. However parameters of this model are difficult to link with structural and anatomical ... [more ▼] A minimal cardiovascular system (CVS) model including mitral valve dynamics has been previously validated in silico. However parameters of this model are difficult to link with structural and anatomical components of the valve. This research describes the integration of a structural model of the mitral valve in an existing closed-loop cardiovascular system (CVS) model [less ▲] Detailed reference viewed: 8 (0 ULg) Left atrial function: pathophysiology, echocardiographic assessment, and clinical applications.; Lancellotti, Patrizio ; et alin Heart (2011) Detailed reference viewed: 6 (2 ULg) European association of echocardiography: research grant programme; ; et al in European Journal of Echocardiography (2011) The European Society of Cardiology (ESC) offers a variety of grants/fellowships to help young professionals in the field of cardiological training or research activities throughout Europe. The number of ... [more ▼] The European Society of Cardiology (ESC) offers a variety of grants/fellowships to help young professionals in the field of cardiological training or research activities throughout Europe. The number of grants has significantly increased in recent years with contributions from the Associations, Working Groups and Councils of the ESC. The European Association of Echocardiography (EAE) is a registered branch of the ESC and actively takes part in this initiative. One of the aims of EAE is to promote excellence in research in cardiovascular ultrasound and other imaging modalities in Europe. Therefore, since 2008, the EAE offers a Research Grant Programme to help young doctors to obtain research experience in a high standard academic centre (or similar institution oriented to clinical or pre-clinical research) in an ESC member country other than their own. This programme can be considered as a valorization of the geographical mobility as well as cultural exchanges and professional practice in the field of cardiovascular imaging. The programme has been very successful so far, therefore in 2012 the EAE has increased its offer to two grants of 25 000 euros per annum each. [less ▲] Detailed reference viewed: 2 (0 ULg) Multiplane two-dimensional versus real time three-dimensional transesophageal echocardiography in ischemic mitral regurgitation.; ; et al in Echocardiography (2011) OBJECTIVES: Intraoperative three-dimensional (3D) transesophageal echocardiography (TEE) has been suggested to be a valuable technique for the evaluation of the mechanisms of ischemic mitral regurgitation ... [more ▼] OBJECTIVES: Intraoperative three-dimensional (3D) transesophageal echocardiography (TEE) has been suggested to be a valuable technique for the evaluation of the mechanisms of ischemic mitral regurgitation (IMR). Studies comparing multiplane two-dimensional (2D) with 3D TEE reconstruction of the mitral valve using the new mitral valve quantification (MVQ) software are lacking. We undertook a prospective comparison between multiplane 2D and 3D TEE for the assessment of IMR. METHODS: We evaluated echocardiographically 45 patients with IMR who underwent mitral valve surgery in our institution. 2D and 3D TEE examinations followed by a 3D offline assessment of the mitral valve apparatus were performed in all patients. Offline analysis of mitral valve apparatus was conducted with QLAB-MVQ. RESULTS: 3D TEE image acquisitions were performed in a short period of time and were feasible in all patients. Real time 3D TEE imaging was superior to 2D in identifying specific mitral scallops (A1, A3, P1, P3) and commissures. When compared with 2D TEE, 3D offline reconstruction of the mitral valve allows an accurate quantification of the shape and diameters of the mitral annulus. Both approaches provide almost similar values for the tenting area and the coaptation depth. The 3D approach gave the advantage of direct calculation of the leaflets angles, tenting volume, and surface of the leaflets. The interpapillary muscles distance at the level of the papillary muscle head was greater in 2D than in 3D. CONCLUSIONS: 3D TEE imaging provides valuable and complementary information to multiplane 2D TEE for the assessment of patients with IMR. [less ▲] Detailed reference viewed: 3 (1 ULg) L'image du mois: un serpent en liberté.ANCION, Arnaud ; MARCHETTA, Stella ; BERTHE, Christian et alin Revue Médicale de Liège (2011) Detailed reference viewed: 18 (3 ULg) [Mitral regurgitation in patients with systolic heart failure: more than a bystander].Lancellotti, Patrizio ; in Revista Espanola de Cardiologia (2011) Detailed reference viewed: 3 (0 ULg) Mathematical multi-scale model of the cardiovascular system including mitral valve dynamics. Application to ischemic mitral insufficiencyPaeme, Sabine ; ; et alin BioMedical Engineering OnLine (2011), 10(1), 86 Valve dysfunction is a common cardiovascular pathology. Despite significant clinical research, there is little formal study of how valve dysfunction affects overall circulatory dynamics. Validated models ... [more ▼] Valve dysfunction is a common cardiovascular pathology. Despite significant clinical research, there is little formal study of how valve dysfunction affects overall circulatory dynamics. Validated models would offer the ability to better understand these dynamics and thus optimize diagnosis, as well as surgical and other interventions. A cardiovascular and circulatory system (CVS) model has already been validated in silico, and in several animal model studies. It accounts for valve dynamics using Heaviside functions to simulate a physiologically accurate “open on pressure, close on flow” law. However, it does not consider real-time valve opening dynamics and therefore does not fully capture valve dysfunction, particularly where the dysfunction involves partial closure. This research describes an updated version of this previous closed-loop CVS model that includes the progressive opening of the mitral valve, and is defined over the full cardiac cycle. Simulations of the cardiovascular system with healthy mitral valve are performed, and, the global hemodynamic behaviour is studied compared with previously validated results. The error between resulting pressure-volume (PV) loops of already validated CVS model and the new CVS model that includes the progressive opening of the mitral valve is assessed and remains within typical measurement error and variability. Simulations of ischemic mitral insufficiency are also performed. Pressure-Volume loops, transmitral flow evolution and mitral valve aperture area evolution follow reported measurements in shape, amplitude and trends. The resulting cardiovascular system model including mitral valve dynamics provides a foundation for clinical validation and the study of valvular dysfunction in vivo. The overall models and results could readily be generalised to other cardiac valves. [less ▲] Detailed reference viewed: 46 (22 ULg) |
||